Dicerna Pharmaceuticals, Inc.DRNA was a big mover last session, as the company saw its shares rise over 14% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.45 to $2.91 in the past one-month time frame.
The company has seen one negative estimate revision in the last 30 days; while the Zacks Consensus Estimate remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Dicerna sports a Zacks Rank #1 (Strong Buy) while its Earnings ESP is positive.
Dicerna Pharmaceuticals, Inc. Price
Another similarly-ranked stock in the same industry is Palatin Technologies, Inc. PTN . You can see the complete list of today's Zacks #1 Rank stocks here .
Just Released - Driverless Cars: Your Roadmap to Mega-Profits Today
In this latest Special Report, Zacks' Aggressive Growth Strategist Brian Bolan explores a full-blown technological breakthrough in the making - autonomous cars. He also spotlights 8 stocks with tremendous gain potential to feed off this phenomenon. Click to see the stocks right now >>
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.